Indication
Vitamin K deficiency induced hypoprothrombinemia
Vitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors. Read more about Vitamin K deficiency induced hypoprothrombinemia
30 drugs 23 manufacturers
Drugs that treat it
Common Vitamin K deficiency induced hypoprothrombinemia therapies.
PHYTONADIONE (phytonadione (vit K1))
PHYTONADIONE (phytonadione (vit K1))
PHYTONADIONE (phytonadione (vit K1))
MEPHYTON (phytonadione (vit K1))
PHYTONADIONE (VITAMIN K1) (phytonadione (vit K1))
PHYTONADIONE (VITAMIN K1) (phytonadione (vit K1))
VITAMIN K (phytonadione (vit K1))
PHYTONADIONE (phytonadione (vit K1))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors.
Affecting the hematologic system, it can develop in neonates due to limited transplacental transfer and low hepatic reserves, or across pediatric and adult populations secondary to severe malnutrition, fat malabsorption disorders, biliary obstruction, or broad-spectrum antibacterial therapy.
Pathophysiologically, insufficient vitamin K impairs the essential hepatic gamma-carboxylation required to synthesize biologically active clotting factors, leading to prolonged prothrombin time, elevated international normalized ratio (INR), and a heightened risk of mucocutaneous, gastrointestinal, or life-threatening hemorrhage.
- merckmanuals.com
Vitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors Affecting the hematologic system, it can develop in neonates due to limited transplacental transfer and low hepatic reserves, or across pediatric and adult populations secondary to severe malnutrition, fat malabsorption disorders, biliary obstruction, or broad-spectrum antibacte...
- nih.gov
Vitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors Pathophysiologically, insufficient vitamin K impairs the essential hepatic gamma-carboxylation required to synthesize biologically active clotting factors, leading to prolonged prothrombin time, elevated international normalized ratio (INR), and a heightened risk of mucocutaneou...
- fda.gov
Affecting the hematologic system, it can develop in neonates due to limited transplacental transfer and low hepatic reserves, or across pediatric and adult populations secondary to severe malnutrition, fat malabsorption disorders, biliary obstruction, or broad-spectrum antibacterial therapy
- nih.gov
Affecting the hematologic system, it can develop in neonates due to limited transplacental transfer and low hepatic reserves, or across pediatric and adult populations secondary to severe malnutrition, fat malabsorption disorders, biliary obstruction, or broad-spectrum antibacterial therapy Pathophysiologically, insufficient vitamin K impairs the essential hepatic gamma-carboxylation required to synthesize biologically active clotting factors, leading to prolonged prothrombin time, elevated inte...
- fda.report
Pathophysiologically, insufficient vitamin K impairs the essential hepatic gamma-carboxylation required to synthesize biologically active clotting factors, leading to prolonged prothrombin time, elevated international normalized ratio (INR), and a heightened risk of mucocutaneous, gastrointestinal, or life-threatening hemorrhage
Personalize your experience
Follow Vitamin K deficiency induced hypoprothrombinemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.